Wyeth Expects 30-40% Sales From Biotech Drugs

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on February 22, 2006

During the ongoing Reuters Biotechnology Summit, Wyeth head of research Robert Ruffalo said that biotech drugs are expected to account for about 30-40% of its sales in the next 5 to 10 years, up from its current 25%. He also mentioned that the company has about 20 biotech products in development, including drugs aimed at obesity and other metabolic conditions, and anti-depressants.

In its Annual Report of Top 10 Pharmaceutical Pipelines, R&D Directions, a magazine focusing on pharmaceutical research and development named Wyeth's pipeline as "The Strongest Primary-Care Pipeline".

...Wyeth R&D has initiated several progressive measures to spur productivity, which has grown from an average 3.3 drugs per year placed into development to 12 drugs per year for the past five years.

More about Wyeth's pipeline from Reuters and Wyeth's website.

[Photo: Wyeth.de]

Related Entries:

Wyeth Pharmaceuticals Opens World's Largest Integrated Biote... - 13 September 2005
Pharmaceuticals from Genetically Engineered Chicken Eggs - 15 January 2007
Top Biotech Hubs for 2007 - 26 February 2007
Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer... - 22 March 2007
Consumers Still Buy Potentially Risky Drugs over the Interne... - 06 July 2007

« Biojewelry: Rings Made Fr... | Main | AlphaTRAK: Glucose Monito... »

Permalink: Wyeth Expects 30-40% Sales From Biotech Drugs

Tags: biotech drugs wyeth sales expects biotech+drugs wyeth+expects expects+sales

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/15984

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for Wyeth Expects 30-40% Sales From Biotech Drugs:

Currently 7.33/10
1
2
3
4
5
6
7
8
9
10

Rating: 7.33 out of 3 vote(s) cast.

Add your response to Wyeth Expects 30-40% Sales From Biotech Drugs:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Gloria Gamat (4)
Ruth Schaffer (10)
Creative Weblogging (4)

This site has 1327 entries and is powered by Creative Weblogging since July 2005.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Are you interested in writing a blog in our network?

See which positions are currently open.

Testimonials

'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'